Literature DB >> 6176491

Subcutaneous degradation of insulin.

R W Stevenson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6176491     DOI： 10.1007/BF00283760

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  16 in total

1.  The effect of aprotinin on the absorption of subcutaneously injected regular insulin in normal subjects.

Authors:  M Berger; H J Cüppers; P A Halban; R E Offord
Journal:  Diabetes       Date:  1980-01       Impact factor: 9.461

2.  Resistance against subcutaneous insulin successfully managed with aprotinin.

Authors:  W A Müller; C Taillens; S Léreret; M Berger; J Philippe; P A Halban; R E Offord
Journal:  Lancet       Date:  1980-06-07       Impact factor: 79.321

3.  Matched glucose responses to insulin administered subcutaneously and intravenously. Evidence for subcutaneous inactivation of insulin.

Authors:  R W Stevenson; T I Tsakok; J A Parsons
Journal:  Diabetologia       Date:  1980-05       Impact factor: 10.122

4.  Importance of insulin absorption, subcutaneous blood flow, and residual beta-cell function in insulin therapy.

Authors:  T Lauritzen; C Binder; O K Faber
Journal:  Acta Paediatr Scand Suppl       Date:  1980

5.  Mobilization of subcutaneously injected tritiated insulin in rats: effects of muscular exercise.

Authors:  M Berger; P A Halban; W A Muller; R E Offord; A E Renold; M Vranic
Journal:  Diabetologia       Date:  1978-08       Impact factor: 10.122

6.  Absorption kinetics of subcutaneously injected insulin. Evidence for degradation at the injection site.

Authors:  M Berger; P A Halban; L Girardier; J Seydoux; R E Offord; A E Renold
Journal:  Diabetologia       Date:  1979-08       Impact factor: 10.122

7.  Apparent insulin resistance due to abnormal enzymatic insulin degradation: a new mechanism for insulin resistance.

Authors:  A McElduff; C J Eastman; S P Haynes; K M Bowen
Journal:  Aust N Z J Med       Date:  1980-02

8.  Diabetes responsive to intravenous but not subcutaneous insulin: effectiveness of aprotinin.

Authors:  G R Freidenberg; N White; S Cataland; T M O'Dorisio; J F Sotos; J V Santiago
Journal:  N Engl J Med       Date:  1981-08-13       Impact factor: 91.245

9.  Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption.

Authors:  J C Pickup; P D Home; R W Bilous; H Keen; K G Alberti
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-31

10.  Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.

Authors:  J Reeve; P J Meunier; J A Parsons; M Bernat; O L Bijvoet; P Courpron; C Edouard; L Klenerman; R M Neer; J C Renier; D Slovik; F J Vismans; J T Potts
Journal:  Br Med J       Date:  1980-06-07
View more
  1 in total

1.  Enhanced bioavailability of subcutaneously injected insulin by pretreatment with ointment containing protease inhibitors.

Authors:  M Takeyama; T Ishida; N Kokubu; F Komada; S Iwakawa; K Okumura; R Hori
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.